Indapamide, a nonthiazide diuretic, exhibits direct vasodilator action as well as natriuretic and diuretic effects. Although calcium antagonist-like activity has been addressed so far, the mechanisms for vasodilator effect are still uncertain. To understand the wide range of indapamide actions, we examined the effects of indapamide on the vascular eicosanoid generation and investigated its mechanisms by using rat vascular smooth muscle cells in culture. Indapamide uniquely increased the prostacyclin generation in the vascular smooth muscle cells in a dose-dependent manner, whereas it did not affect the vasoconstrictor thromboxane A 2 . Thiazide diuretics lowered the prostacyclin generation, while nonthiazide derivatives did not affect the biosynthesis. Enzymatic analysis revealed that indapamide affected neither [ A n o-chlorobenzenesulfonamide molecule is a prototype of various diuretics including thiazide and nonthiazide diuretics (Figure 1 ). Although natriuretic and diuretic effects are mainly due to the common structure of o-chlorobenzenesulfonamide, varied side chains give the diuretics characteristic properties. In this context, indapamide diuretic comprises an indoline molecule and uniquely exhibits a direct vasodilator action as well as a natriuretic effect on the cortical collecting duct in the kidney.
A n o-chlorobenzenesulfonamide molecule is a prototype of various diuretics including thiazide and nonthiazide diuretics ( Figure 1 ). Although natriuretic and diuretic effects are mainly due to the common structure of o-chlorobenzenesulfonamide, varied side chains give the diuretics characteristic properties. In this context, indapamide diuretic comprises an indoline molecule and uniquely exhibits a direct vasodilator action as well as a natriuretic effect on the cortical collecting duct in the kidney. 1 - 4 The vasodilator effect is assumed to be caused by its calcium channel blocker-like activity 5 or endothelium-derived relaxing factor-mediated mechanism. 6 However, the exact mechanism is not fully understood.
On the other hand, the biosynthetic system for eicosanoid (prostaglandins and thromboxanes) is well demonstrated in the vascular smooth muscle cells (VSMC) of rats. 7 -8 Prostacyclin (PGI 2 ), a major product of arachidonate metabolism in VSMC, has a powerful vasodilator action and attenuates the vasoconstrictor response to vasoactive substances. 9 The eicosanoid metabolism is a major component participating in the regulation of the constriction-relaxation mechanism of VSMC.
To understand the wide range of indapamide effects, it seems important to disclose the relevance of the eicosanoid system in the vascular wall to the extrarenal indapamide effects. Thus in this study, we investigated the influences of indapamide on the eicosanoid generation in VSMC by using cultured VSMC of rats and attempted to define the mechanisms for its alteration. Ross et al. 10 Briefly, rats were decapitated without anesthesia. The descending aortas were immediately obtained, and the surrounding connective tissue was carefully removed with forceps and gauze. Then, explants of ~5 mm 2 were placed on a 94x21 mm polystyrene dish (Corning-Iwaki Glass Co., Tokyo, Japan) with the intimal side attached to the dish. Ten milliliters Dulbecco's modified Eagle medium (DMEM) (GIBCO Labs., Grand Island, New York), supplemented with 20% (vol/vol) fetal bovine serum (FBS) (GIBCO Labs.), penicillin (100 units/ml), and streptomycin (100 /ig/ml), was gently added. The dishes were kept at 37° C in a humidified atmosphere of 95% air and 5% CO 2 . The cells reached confluency 10 days after inoculation. They were harvested by brief exposure to Hanks' medium, supplemented with 0.05% (wt/vol) trypsin and 0.02% (wt/vol) ethylenediaminetetraacetic acid disodium, and transferred into a new dish. At this stage, the cells were designated as the first passage. FBS was reduced to 10% (vol/vol) in the subsequent media. Harvesting was repeated when the cell growth became confluent. VSMC from the fourth to the sixth passage were used in the following studies. Figure 2A shows the appearance of the cells in primary culture and in the sixth generation ( Figure  2B ) on a phase contrast microscope (model IMT Olympus microscope, Olympus Optical Co., Tokyo, Japan). The cultured VSMC were characterized by the "hills and valleys" growth pattern on a light microscope, 
Effects of Diuretics on Eicosanoid Generation in Vascular Smooth Muscle Cells
The confluent VSMC in the 35x18 mm six-well polystyrene dish were washed three times with FBSfree Dulbecco's balanced phosphate-buffered saline solution (D-PBS) (GIBCO Labs.). Then, the VSMC were continuously cultured for 1 hour in D-PBS with 10" 6 M arachidonic acid and a given concentration of various diuretics. Eicosanoid released in a D-PBS medium was measured by direct radioimmunoassay. The cells were detached with brief exposure to 0.05% trypsin solution and washed repeatedly with D-PBS. The cells were homogenized with a Polytron blender (Kinematica GmbH, Littau, Switzerland), and the protein content was measured by the method of Lowry et al. 12 Direct radioimmunoassay was performed according to the previous method. 1314 Briefly, the assay mixture consisted of 0.1 ml [ 3 H]eicosanoid (10 4 disintegrations per minute), 0.1 ml diluted sample or standard solution, and 0.1 ml diluted antibody solution. The assay mixture was incubated at 4° C for 24 hours. To separate the bound from the free [ 3 H]eicosanoid, 0.1 ml dextran-coated charcoal solution (2.5% charcoal and 0.25% dextran) was added, and the mixture was immediately centrifuged at l,000g at 4° C for 5 minutes. Radioactivity of the bound [ 
b)
Anti-6-keto-prostaglandin Fi a (6-k-PGF la ) serum cross-reacted 1% with prostaglandin E^ (PGE2), 2% with prostaglandin F^ (PGF^), 0.08% with prostaglandin D 2 (PGD 2 ), 0.01% with thromboxane B^, and less than 0.001% with arachidonate. Antithromboxane B2 serum cross-reacted 0.005% with 6-k-PGF la , 0.007% with PGE^ 0.018% with P G F0 .06% with PGD 2 , and less than 0.0001% with arachidonate. Anti-PGEj serum cross-reacted 0.4% with 6-k-PGF la , 0.5% with P G F^ 0.1% with PGD 2 , 0.02% with thromboxane B^ and less than 0.001% with arachidonate.
Effects of Diuretics on Liberation of [C]Arachidonate From Vascular Smooth Muscle Cells
Cells (10 5 ) were seeded onto a 35x18 mm six-well polystyrene dish with 2 ml DMEM containing 10% (vol/vol) FBS. When the VSMC became confluent, the medium was reduced to 2 ml DMEM with 5% (vol/vol) FBS and 0.5 /uCi [ : vol) and purified with silicic acid thin layer chromatography. The radioactivity in the zone corresponding to arachidonate was counted by an automatic scintillation counter. The recovery rate of this extraction method averaged 96 ±1% (n=6).
Protein content of the cells was measured with the same procedure as described previously. 2 Synthase Activity PGI 2 synthase activity was determined with use of a modified method of Salmon et al. 15~17 Briefly, 50 fi\ of the microsomal fraction (10 5 g pellet) of VSMC, enriched with PGI 2 synthase, was preincubated in 50 fi\ 25 mM Tris (hydroxymethyl)aminomethane HC1 (Tris-Cl) (Sigma Chemical Co., St. Louis, Missouri) containing 100 mM NaCl and a given concentration of diuretic at 4° C for 15 minutes (pH 7.5). The reaction was initiated at 37° C by addition of 10 /xl prostaglandin H 2 (PGH 2 ) (0.5 fig in acetone) (Ono Pharmaceutical Co., Ltd, Osaka, Japan) and terminated with 50 ul of 50 mM FeCl 2 solution after 3 minutes. The generated PGI 2 was measured by the radioimmunoassay as 6-k-PGF 1<r To measure the nonspecific conversion of PGH 2 to PGI 2 , we measured the PGI 2 generation by boiled enzymatic fraction. The nonspecific conversion was less than 1%. Moreover, the amount of PGI 2 generated by the microsomal fraction was negligible when the substrate PGH 2 was not added to the assay mixture.
Effects of Diuretics on PGI

Measurements of Scavenging Effects
The antioxidant activity of indapamide and some diuretics, or a-tocopherol, was assessed by using a stable free radical, a,a-diphenyl-/3-picrylhydrazyl (DPPH) (Wako Pure Chemical Industries, Osaka, Japan), according to the method of Blois. 18 The reduction of 10~4 M DPPH was initiated by addition of a given concentration of the test compound. The conversion of DPPH to its reduced form was recorded at 25° C for 30 minutes by a Hitachi Model U-3200 spectrophotometer (Hitachi, Ltd, Tokyo, Japan) at 517 nm wavelength.
The antioxidant activity of indapamide was assessed by an inhibitory activity to the formation of malondialdehyde (MDA) in rat brain homogenate, which according to Kubo et al, 19 is an end product of lipid peroxides. In brief, the brains from 7-week-old male Wistar rats (Kitayama LABES Co., Kyoto, Japan) were isolated after the rats were decapitated. The cortical tissues were homogenized in ice-chilled 50 mM phosphate-buffered saline solution at pH 7.4 using an Ultra-Disperser (Yamato Scientific Co., Ltd, Tokyo, Japan). The homogenate was centrifuged at l,300g for 10 minutes at 4° C. The supernatant was diluted with the buffer to 2 mg/ml for the protein concentration. This prepared supernatant was incubated at 37° C for 30 minutes with a given concentration of diuretics or a-tocopherol. The reaction was terminated by addition of 20% trichloroacetic acid (1 ; 1, vol : vol), and the mixture was immediately centrifuged at 2,000g for 15 minutes at 4° C. The supernatant (2 ml) was heated at 100° C for 15 minutes with 0.4 ml 0.12 M thiobarbituric acid solution at pH 7.4. The optical absorbance of MDA was measured at 532 nm by the spectrophotometer. MDA in a medium before the assay was determined so that the net MDA production during the reaction could be measured. Protein concentration was measured according to the method of Lowry et al. 12 We also explored the antioxidant effects of indapamide using the xanthine-xanthine oxidase free radical generating system. 20 " 22 A given concentration of the test compound in 15 y\ was mixed with 1.5 ml 50 mM linolenic acid (Sigma Chemical Co.) and 0.15 ml 0.5 mM xanthine (Sigma Chemical Co.) in 10 mM phosphate-buffered solution including 1% sodium dodecyl sulfate at pH 7.4. The reaction was initiated at 37° C by addition of 0.15 ml (5 units/ml) xanthine oxidase (Sigma Chemical Co.) and terminated with 1.5 ml 20% trichloroacetic acid after 10 minutes. Peroxidation of linolenic acid was measured as MDA formation. Briefly, the assay mixture was spun at 2,500g for 10 minutes at 4° C. An aliquot of the supernatant was mixed with 0.2% butylated hydroxytoluene and 0.02 M thiobarbituric acid solution. The mixture was treated at 100° C for 10 minutes. Absolute n-butanol was added to the ice-chilled mixture (1:1, vol : vol), which was spun again at l,200g for 5 minutes at 4° C. The MDA in the organic phase was measured with a spectrophotometer at 532 nm. The nonspecific oxidation in this assay system was checked under the experimental condition without xanthine-xanthine oxidase. Moreover, we confirmed that indapamide did not interfere with the xanthinexanthine oxidase reaction by measuring the formation of uric acid in the assay system by a modified colorimetric method with the uricase-catalase system of Kageyama 23 (Uric Acid C-Test, Wako Pure Chemical Industries, Ltd., Osaka, Japan).
Finally, we attempted to examine the effects of diuretics on the inhibitory activity of 15-hydroperoxyarachidonate (15-HPETE) to PGI 2 synthase. Enzymatic fraction (50 /A) was preincubated at 4° C for 15 minutes in a mixture of 50 fil of 25 mM Tris-Cl buffered solution with 100 mM NaCl and 15-HPETE (0-2,000 ng/ml) in the absence or presence of 5 x 10" 5 M diuretics. PGI 2 synthase activity was determined according to the procedure described in this section.
Reagents
The reagents were all of analytical grade. Authentic eicosanoids and related compounds were a gift from Ono Pharmaceutical Co., Ltd (Osaka, Japan). Mefruside was supplied by Yoshitomi Pharmaceutical Co., Ltd (Osaka, Japan); furosemide, trichloromethiazide, and hydrochlorothiazide were obtained from Sigma Chemical Co. (St. Louis, Missouri), and radioactive materials were purchased from Amersham International pic (Buckinghamshire, England).
Statistical Analysis
The values were expressed as mean±SEM. The difference was assessed by the Student's / test or one-way analysis of variance.
Results
The direct effect of indapamide, a nonthiazide diuretic, on the vasodilator PGI 2 generation in VSMC is shown in Figure 3 . The PGI 2 production was significantly stimulated with the indapamide diuretic in a dose-dependent manner, increasing by 54% at a concentration of 10~4 M when compared with the control value. In contrast, the diuretic did not influence thromboxane biosynthesis in the VSMC ( Table 1) . The VSMC had a small capacity in the generation of PGEj and P G F^ Indapamide tended to increase vasodepressor PGE 2 generation in VSMC, although we could not find a significant dose-dependency. PGF^ generation was not altered by the diuretic ( Table 1) .
The PGI 2 stimulatory effect was uniquely observed in indapamide alone. As shown in Table 2 , the thiazide diuretics, that is, trichloromethiazide and hydrochlorothiazide, produced a decrease in PGI 2 generation, whereas the thromboxane generation was not altered. The effects on PGI 2 generation varied among the nonthiazide diuretics. Mefruside, a sulfonyl group diuretic (Figure 1 ), did not influence the PGI 2 biosynthesis in the VSMC (Table 3) . Although furosemide is classified as an aminocarbonyl group, which is structurally related to indapamide (Figure 1) , it did not affect the PGI 2 generation (Table 3) . Furosemide exhibited a significant increase in thromboxane A 2 production when tested at a higher concentration.
To explore the mechanisms for the unique PGI 2 stimulatory effect of indapamide, we analyzed enzymaticalry the eicosanoid biosynthesis. First, we investigated the liberation of [ 14 C]arachidonate from the cellular membrane of VSMC, into which the radioactive arachidonate had been incorporated. In comparison, bradykinin and the calcium ionophore A23187, both of which are the stimulators of phospholipase A 2 , were also examined. As shown in Figure 4 , the control compounds were found to stimulate, in a dosedependent manner, the [ 14 C]arachidonate liberation in this assay system. However, the indapamide diuretic did not produce a significant change in the arachidonate liberation.
Second, we examined the direct effect of indapamide on PGI 2 synthase in the microsomal fraction of the VSMC ( Figure 5 ). The PGI 2 synthase activity was not influenced by indapamide at concentrations ranging from 10~9 to 10~4 M. Furosemide, the control compound, also did not affect the PGI 2 synthase activity.
Next, we explored the antioxidant effects of indapamide on the eicosanoid generation. Indapamide diuretic significantly promoted the reduction of a stable free radical, a,a-diphenyl-/3-picrylhydrazyl, in a dose-dependent manner ( Figure 6 ). However, neither trichloromethiazide nor furosemide facilitated the reduction. 
FIGURE 4. Plot showing effects of indapamide on arachidonate liberation from vascular smooth muscle cells (VSMC).
• We examined the indapamide effects on MDA formation in the rat brain homogenate (Figure 7 ). Indapamide was found to markedly reduce the MDA formation in the rat brain homogenate. Moreover, the dose for equipotency of the scavenging effect was significantly smaller in indapamide than a conventional scavenger such as a-tocopherol. The thiazide diuretic and furosemide did not exhibit the antioxidant effects on the MDA formation in the homogenate.
To ascertain the possible scavenging property of indapamide, we examined its effects on the peroxidation of linolenic acid by the free radical generating system of xanthine-xanthine oxidase. We found that this system caused the peroxidation of linolenic acid, which was inhibited 37% with superoxide dismutase coupled with catalase (4.505±0.155 vs. 2.820±0.232 nmol MDA/ml/10 min,p<0.005). By using this assay system, we assessed the scavenging effects of indapamide. As depicted in Figure 8 the formation of MDA in a dose-dependent manner, which became 29% of the control value at 10" 4 M. In contrast, neither trichloromethiazide nor furosemide affected the formation.
In this context, we examined whether the compound could attenuate the inhibitory activity of free radicals to PGI 2 synthase ( Figure 9 ). As shown in the open circles, 15-HPETE, a free radical provider and potent inhibitor to PGI 2 synthase, suppressed the PGI 2 synthase activity in a dose-dependent manner. However, when 5 x 10~5 M indapamide occurred in the assay mixture, the inhibitory activity of 15-HPETE was significantly lowered, thereby shifting the doseresponse curve toward the right. Furosemide did not produce any alteration in the dose-response curve. Discussion The VSMC were primarily cultured and maintained according to the standard method of Ross et al. 10 The cells were characterized by various properties of growth pattern, which are characteristic of vascular smooth muscle cells. 8 - 11 Moreover, the origin of vascular smooth muscle was confirmed as well by light and electron microscopy and immunohistochemical findings. 8 In this study, we demonstrated that indapamide was a potent stimulator of vasodilator PGI 2 generation in VSMC. Indapamide did not affect the vasoconstrictor thromboxane A 2 , thereby shifting the PGI 2 -to-thromboxane A 2 ratio toward a vasodilator state. The enhanced PGE^ generation, although a small amount, is likely to produce vasodilation as 24 which finally leads to a decrease in the cytosolic calcium concentration. 25 Conversely, vasoconstrictor thromboxane A 2 enhances the cytosolic calcium through phosphoinositide metabolism and a receptor-mediated calcium channel mechanism. 26 Although the involvement of the eicosanoid system in the direct vasodilation by indapamide has not been proven so far, the increase in the PGI 2 -to-thromboxane A 2 ratio observed in the VSMC could be one of the factors that cause vasodilation. To address these questions more directly, however, we might be required to test the prostaglandin inhibitors in the direct vasodilator action of the indapamide diuretic.
We showed that indapamide enhanced the elimination of the stable free radical DPPH and reduced the formation of MDA in the rat brain homogenate. More directly, we demonstrated that indapamide lowered the oxidation of linolenic acid in the xanthinexanthine oxidase system. It has been reported 21 that xanthine-xanthine oxidase is a free radical-generating system and that the oxidation of fatty acids is a free radical-mediated reaction. 20 - 22 We also showed that 0.5 unit superoxide dismutase inhibited the oxidation 37% in this assay system. These data clearly indicate that indapamide has marked antioxidant effects particularly at the relatively higher concentrations. In addition, since such antioxidant properties were found in neither trichloromethiazide nor furosemide, the scavenging effect is unique to the indapamide diuretic.
Free radicals are more destructive to PGI 2 synthase and the cyclooxygenase-hydroperoxidase complex becomes the target as well. 2728 Indeed, ONO-3144 (Ono Pharmaceutical Co., Ltd, Osaka, Japan), a potent antioxidant and anti-inflammatory drug, as well as MK-447 27 -28 reportedly enhances PGI 2 and PGEj formation while thromboxane A 2 generation is somehow lowered in guinea pig macrophages. 29 The enhanced PGI 2 generation could be partly explained by a diversion of endoperoxide from MDA formation to PGI 2 synthesis. However, it seemed probable that the antioxidant effect of indapamide protects PGI 2 synthase from the attacks of endogenous free radicals, thereby increasing PGI 2 formation in VSMC. In fact, the enzyme analyses revealed that arachidonate liberation was not responsible for the enhanced PGI 2 generation in indapamide-stimulated VSMC. Moreover, we found that indapamide failed to directly activate PGI 2 synthase in a cell-free assay system. In contrast, this diuretic attenuated PGI 2 synthase inhibitory activity of 15-HPETE, a provider of free radicals and a powerful inhibitor of PGI 2 synthase. These data are supportive of the involvement of scavenging effects in the enhanced PGI 2 generation by indapamide diuretic.
In this context, it is reported that PGH synthase generates superoxide in the presence of reduced nicotinamide-adenine dinucleotide or nicotinamideadenine dinucleotide B'-phosphate. 30 The eumination of superoxide generated in the formation of PGH 2 is expected to enhance PGH 2 production, which would lead to increased PGE2 generation. 29 Hence, the fact that indapamide tended to increase the PGE2 generation in VSMC could be accounted for by such scavenging effects on the PGH 2 formation.
From a viewpoint of a structure-activity relation, the common structure of o-chlorobenzenesulfonamide, the basal component for natriuretic effects, is irrelevant to PGI 2 stimulation observed in indapamide (Figure 1 ). Because PGI 2 stimulation and scavenging effects were found in neither mefruside nor furosemide, the side chains appeared to be largely responsible for these various properties. Moreover, there are naturally a few types of free radicals, that is, superoxide, hydroxy radical, singlet oxygen, or peroxide. It is still uncertain what type of free radicals is scavenged by the indapamide diuretic. Electrochemical analyses are needed to reveal the mechanisms for the antioxidant effects of this diuretic.
It has been reported that the oral dosage of indapamide for obtaining sufficient antihypertensive effects in rats is more than 1 mg/kg body wt, 31 -32 which is about 10 times as much as the dosage for human subjects. 33 In rats, a single oral dosage of 1 mg/kg is reported to reach the peak plasma concentration of 1.3 jig/ml, which is equivalent to 3.5 xlO" 6 M. 34 ' 35 Based on these studies, the indapamide concentrations used in our in vitro study are probably attainable in rat plasma.
Finally, indapamide exhibited the enhanced PGI 2 generation and scavenging effects in vitro. These properties are assumed to be protective from the arteriosclerotic changes or tissue damages caused by blood pressure elevation. 36 ' 37 We do not have in vivo data available for the indapamide effects. In humans, however, it has been reported that indapamide does not deteriorate renal function even when given to patients with renal impairment. 38 Thus, our next goal is to test whether the indapamide diuretic exhibits in vivo protective effects against organ damage in hypertensive models. Experiments are in progress to address these questions.
